229 related articles for article (PubMed ID: 24817598)
1. Sample-size calculation and reestimation for a semiparametric analysis of recurrent event data taking robust standard errors into account.
Ingel K; Jahn-Eimermacher A
Biom J; 2014 Jul; 56(4):631-48. PubMed ID: 24817598
[TBL] [Abstract][Full Text] [Related]
2. Blinded and unblinded internal pilot study designs for clinical trials with count data.
Schneider S; Schmidli H; Friede T
Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
[TBL] [Abstract][Full Text] [Related]
3. A SAS macro for sample size adjustment and randomization test for internal pilot study.
Wang S; Xia J; Yu L; Li C; Xu L
Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069
[TBL] [Abstract][Full Text] [Related]
4. Blinded sample size re-estimation for recurrent event data with time trends.
Schneider S; Schmidli H; Friede T
Stat Med; 2013 Dec; 32(30):5448-57. PubMed ID: 24105855
[TBL] [Abstract][Full Text] [Related]
5. Blinded sample size reestimation with count data: methods and applications in multiple sclerosis.
Friede T; Schmidli H
Stat Med; 2010 May; 29(10):1145-56. PubMed ID: 20146203
[TBL] [Abstract][Full Text] [Related]
6. Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trials.
Friede T; Schmidli H
Methods Inf Med; 2010; 49(6):618-24. PubMed ID: 20686735
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints.
Beisel C; Benner A; Kunz C; Kopp-Schneider A
Biom J; 2017 May; 59(3):511-530. PubMed ID: 28263395
[TBL] [Abstract][Full Text] [Related]
8. Internal pilots for observational studies.
Gurka MJ; Coffey CS; Gurka KK
Biom J; 2010 Oct; 52(5):590-603. PubMed ID: 20857422
[TBL] [Abstract][Full Text] [Related]
9. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
Jensen K; Kieser M
Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
[TBL] [Abstract][Full Text] [Related]
10. Variance estimation in clinical studies with interim sample size re-estimation.
Miller F
Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
[TBL] [Abstract][Full Text] [Related]
11. Sample size calculation for recurrent events data in one-arm studies.
Rebora P; Galimberti S
Pharm Stat; 2012; 11(6):494-502. PubMed ID: 23024035
[TBL] [Abstract][Full Text] [Related]
12. Properties of internal pilots with the univariate approach to repeated measures.
Coffey CS; Muller KE
Stat Med; 2003 Aug; 22(15):2469-85. PubMed ID: 12872303
[TBL] [Abstract][Full Text] [Related]
13. Robustness of methods for blinded sample size re-estimation with overdispersed count data.
Schneider S; Schmidli H; Friede T
Stat Med; 2013 Sep; 32(21):3623-35. PubMed ID: 23595966
[TBL] [Abstract][Full Text] [Related]
14. Accounting for variability in sample size estimation with applications to nonadherence and estimation of variance and effect size.
Fay MP; Halloran ME; Follmann DA
Biometrics; 2007 Jun; 63(2):465-74. PubMed ID: 17688499
[TBL] [Abstract][Full Text] [Related]
15. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
Mütze T; Friede T
Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
[TBL] [Abstract][Full Text] [Related]
16. Blinded continuous monitoring in clinical trials with recurrent event endpoints.
Friede T; Häring DA; Schmidli H
Pharm Stat; 2019 Jan; 18(1):54-64. PubMed ID: 30345693
[TBL] [Abstract][Full Text] [Related]
17. Blinded sample size reestimation in non-inferiority trials with binary endpoints.
Friede T; Mitchell C; Müller-Velten G
Biom J; 2007 Dec; 49(6):903-16. PubMed ID: 17726715
[TBL] [Abstract][Full Text] [Related]
18. Sample size calculation for comparing two negative binomial rates.
Zhu H; Lakkis H
Stat Med; 2014 Feb; 33(3):376-87. PubMed ID: 24038204
[TBL] [Abstract][Full Text] [Related]
19. Sample size re-estimation for survival data in clinical trials with an adaptive design.
Togo K; Iwasaki M
Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
[TBL] [Abstract][Full Text] [Related]
20. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
Kombrink K; Munk A; Friede T
Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
